article thumbnail

The future of cancer immunotherapy: exclusive webinar

Drug Discovery World

Veronique Baron from BPS Bioscience discusses the tools required to research and develop new oncology therapies, such as proteins, antibodies, cell lines, assay kits and viral tools. Hosted by DDW and supported by BPS BioScience and AcroBiosystems, ‘Cancer immunotherapy – where will the future opportunities be?’ Register now.

article thumbnail

Learn about cancer immunotherapy in this webinar

Drug Discovery World

Veronique Baron from BPS Bioscience discusses the tools required to research and develop new oncology therapies, such as proteins, antibodies, cell lines, assay kits and viral tools. Hosted by DDW and supported by BPS BioScience and AcroBiosystems, ‘Cancer immunotherapy – where will the future opportunities be?’ Register now.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

During a 2021 webinar on optimising assay development for hit identification, a survey asked over 50 drug discovery scientists, “Which goal is the highest priority when developing a drug discovery assay?”. Three common questions regarding the challenges when considering outsourcing partners for drug discovery.

article thumbnail

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

Assays are tests designed to assess various properties (like potency) of chemical or biological samples. In an effort to further explain its current views on potency assurance, the FDA also recorded a webinar to accompany the new draft. What does progressive implementation of a potency assurance strategy mean?